Professionals >

The world of international business is full of opportunity, but can be a complicated, and even dangerous, place. The promise of a new market can be accompanied with risks and instabilities, which business needs to avoid. In addition, companies face a dizzying array of regulatory requirements, trade laws, global guidelines, and varying local business practices, which need to be understood in order to succeed.  Success in a new market, especially emerging markets, is not just about doing due diligence or lining up financing. Success often depends on investing in the right relationships and building a network of support, and entering a market with a predicable regulatory environment.

Thinking of expanding into a new market but want to understand the risks?

We will research the political, economic, and regulatory risk factors and present you with an objective, independent, and comprehensive analysis. We will dig beyond the surface to probe the reality of "Country X" as a place to conduct your business.  Leveraging our deep knowledge of global trade agreements, we can also conduct comprehensive analyses to determine the most promising avenues for sourcing products into new markets and/or exporting from new markets.

Need to understand the regulatory requirements associated with exporting to a new market?

We know well the regulatory structures companies must contend with as they enter new markets. We will help you comply with the rules, and we will work with you step by step through the process to minimize surprises. 

Unsure of what political or regulatory barriers might impede your ability to effectively compete in a new market, and how they might be mitigated?

We will identify potential barriers — from discriminatory rules to equity caps — that may keep you from effectively doing business in a new market. In addition, we can devise strategies to persuade governments to change those rules and make them work for you.

If you are an overseas corporation looking to sell products or services in the U.S. market, we will explain the trade and other regulations that may apply.

Want to ensure a smooth market entry by investing in strong relationships?

We have found that companies and industries that make "policy investments" in advance of entering a market receive substantial dividends in the form of closer and more responsive relationships with the host government, and more industry-friendly policies and regulations. We conceive and launch private-public partnerships with government ministries to position companies as allies, thought leaders and solutions providers, and we activate our networks to make sure they have support from the highest levels.

Need to obtain a license to operate?

We will craft a customized engagement strategy to position your company to obtain licenses to operate ahead of competitors.

Case Studies

  • For one of the largest managed health care companies in the United States, we advised on the key considerations related to entering foreign markets. This included a review of: the structure of the health care system; the state of domestic competition; relevant laws and regulations; market access considerations; and political/economic risk factors. Management used our analysis to designate priority markets for its globalization strategy.
  • For a major auto manufacturer seeking to enter the U.S. market, C&M International analyzed the domestic political environment affecting the automotive sector and assessed the political risks associated with the company's U.S. strategy.
  • For several major financial services companies, we helped to secure licenses to operate in key Asian markets, such as China and Vietnam.
  • For one of the world's leading technology companies, we helped shift the policy environment to better position the company in key Asian markets.
  • For a major consumer goods company, we helped support its entry into the Vietnam market by creating a public-private partnership program with Vietnamese regulators.

View More

"Global Environmental Reporting Standards: What You Need To Know," (November 22, 2021). Contacts: Christopher D. Gundermann, Ryan MacFarlane
Client Alert/Newsletter
POLITICO Weekly Trade: Biden's Trade Officials Begin Deal-Less Tour Of Asia POLITICO (November 15, 2021)
Media Mentions
Biopharma And Medical Device Trends Investors Should Watch In 2022 (November 10, 2021). Authors: Nicholas J. Diamond, and Jameyson Price.
Publications
Rewind: On revivifying Trade Talks Inside U.S.Trade (August 30, 2021)
Media Mentions
With FDA Approval Of First COVID-19 Vaccine, Let The Mandates Begin: US Military, Disney World, CVS Health And More USA Today (August 24, 2021)
Media Mentions
Crowell & Moring International’s Himamauli Das Named Acting Director of FinCEN (Aug.06.2021)
Firm News/Announcement
Former USTR Officials: U.S. Needs ‘Bite-Sized’ Approach To Trade With India Inside U.S. Trade (July 7, 2021)
Media Mentions
Adapting Human Rights Due Diligence For Renewable Energy—Key Points (July 2, 2021). Author: Nicholas J. Diamond.
Publications
Procedural versus Substantive Reforms: Is the Work of UNCITRAL WGIII Worth the Wait? (June 27, 2021). Assistant Editor: Nicholas J. Diamond.
Publications
Vaccine Passport Success Rests On True Privacy, Equity, Security (May 26, 2021). Authors: Jodi G. Daniel, Nicholas J. Diamond, and Roma Sharma.
Publications

To view more News & Events for this area, please go to our desktop site.

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2021
Attorney advertising - prior results do not guarantee a similar outcome.